<DOC>
	<DOCNO>NCT00628901</DOCNO>
	<brief_summary>The purpose study demonstrate comparability Contour SE™ Microspheres Embosphere® Microspheres achieve post UFE fibroid devascularization woman symptomatic uterine fibroid .</brief_summary>
	<brief_title>A Prospective Study Comparing Contour SE™ Microspheres Embosphere® Microspheres Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization ( UFE )</brief_title>
	<detailed_description>The purpose prospective randomize single-center study demonstrate comparability use Contour SE™ Microspheres ( 700-900µ 900-1200µ ) use near stasis endpoint Embosphere® Microspheres ( 500-700µ ) use `` prune tree '' endpoint achieve post UFE fibroid devascularization woman symptomatic uterine fibroid . The study demonstrate ( use contrast enhance Magnetic Resonance Imaging ( MRI ) baseline 24-hours post embolization ) uterine fibroid successfully devascularized use embolization protocol . Contrast enhance MRI perform baseline , 24-hours , 3-months post UFE . The subject follow 12-months post UFE change baseline symptom severity ( Quality Life ( QoL ) Questionnaire ) assess 3 month 12 month .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Leiomyomatosis</mesh_term>
	<criteria>One follow symptom : abnormal menstrual bleeding , infertility related fibroid , pelvic pain , and/or bulk/pressure relate symptom attribute fibroid : i.e. , pelvic pressure , abdominal enlargement , abdominal bloating , gastrointestinal pressure symptom ( backache , constipation ) , dysfunction urinary bladder ( urinary frequency , urinary retention ) , vaginal pressure , rectal pressure . Severity symptom ( ) warrant invasive treatment Willing able complete followup requirement outline study design section protocol Willing sign consent form Active pelvic inflammatory disease infection Any malignancy pelvic region Endometrial neoplasia hyperplasia Presence one submucosal fibroid ( ) 50 % growth uterine cavity Presence pedunculated serosal fibroid dominant fibroid ( ) Fibroids significant collateral feeding vessel uterine artery Presence artery supply fibroid large enough accept 700900 micron 9001200 micron microspheres Coagulopathy Atypical anatomy allow bilateral UFE Subject know severe contrast allergy Subjects know moderate severe renal disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Leiomyoma</keyword>
	<keyword>Uterine Fibroids</keyword>
	<keyword>Uterine Fibroid Embolization ( UFE )</keyword>
	<keyword>Uterine Artery Embolization ( UAE )</keyword>
	<keyword>Uterine Neoplasms</keyword>
	<keyword>Menorrhagia</keyword>
</DOC>